Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis
David W. Kubiak(Harvard University), Francisco M. Marty(Brigham and Women's Hospital), Anne McDonnell(Brigham and Women's Hospital), Jorge O. Delgado-Flores(Brigham and Women's Hospital), Emily Mui(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Julie M. Bryar(Harvard University)
Cited by 62
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981